Group 5A: All Cancers; Brain Metastasis; Leptomeningeal Disease; HER3 Antibody-Drug Conjugates; Clinical Trials

Poster #TPS2091: Patritumab deruxtecan (HER3-DXd) in active brain metastases from metastatic breast and non-small cell lung cancers, and leptomeningeal disease from advanced solid tumors: The TUXEDO-3 phase II trial.

Poster #TPS3164: HERTHENA-PanTumor01: A global, multicohort, phase 2 trial of HER3-DXd in relapsed/refractory metastatic solid tumors.


Jun 13 2024


2:00 pm - 3:30 pm

Zoom Webinar